Results 271 to 280 of about 239,171 (312)
Small Intestinal Bacterial Overgrowth Is a Predictor of Overt Hepatic Encephalopathy in Patients with Liver Cirrhosis. [PDF]
Sakamaki A+9 more
europepmc +1 more source
Our study provides a comprehensive multi‐omics profile of aging, integrating proteomic, metabolomic, and metagenomic analyses across diverse tissues and plasma. We identified the synergistic amplification of the circulating complement system and tissue‐wide immunoglobulin accumulation as key molecular drivers of inflammaging.
Feng Zhang+17 more
wiley +1 more source
Effects of nocturnal snacks on body composition in patients with liver cirrhosis. [PDF]
Yu YB+6 more
europepmc +1 more source
Novel biomarker emergence plays a critical role in improving CHB management. Advances in sensitive detection methods, AI, and large‐scale data platforms have independently contributed to biomarkers while driving the development of multi‐omics approaches.
Yaru Shi, Rong Fan
wiley +1 more source
Nursing care for patients with liver cirrhosis undergoing surgery for esophageal variceal bleeding in an integrated healthcare system. [PDF]
Su WX, Li YF, Zhu YJ, Li DW.
europepmc +1 more source
Abstract Background Preventable medication‐related readmissions (pMRRs) are a significant contributor to older adult morbidity, mortality, and health care costs. There are currently no specific screening tools for identifying patients at a high risk of pMRRs.
Nicole Schönenberger+4 more
wiley +1 more source
Clinical analysis of Klebsiella pneumoniae infection in patients with liver cirrhosis in Beijing. [PDF]
Zhang Y, Zhao H, Ji SB, Xing HC.
europepmc +1 more source
Relationship between coagulopathy score and survival in critically ill patients with liver cirrhosis and sepsis: a retrospective study. [PDF]
Wang T+9 more
europepmc +1 more source
Serum DCP may serve as an optimal biomarker for the diagnosis of HCC, but its accuracy appears to be influenced by liver function. The serum DCP may also serve as a biomarker for liver resection and interventional therapy of HCC, but is not promising for systemic treatment. ABSTRACT Background This retrospective multicenter study is aimed at evaluating
Hongying Bu+12 more
wiley +1 more source